Post-myocardial infarction risk stratification in elderly patients.

BACKGROUND The purpose of this study was to examine the use of post-myocardial infarction (MI) risk stratification in the elderly. Although expert panels have recommended risk stratification after MI, limited data are available on whether patients actually undergo suggested testing. In particular, concern has been raised that the elderly, who are at high risk for recurrent ischemia and short-term death, are not referred as often as younger patients for post-MI testing. METHODS We studied the records of 192,311 Medicare patients (age > or = 65 years) admitted with MI between January 1992 and November 1992. By combining Medicare part A and part B data, we created a longitudinal record of patient care within 60 days of an MI admission. We describe the pattern of post-MI testing for ischemia and left ventricular function and outcomes as a function of patient age. RESULTS Patients > or = 75 years of age were significantly less likely than patients 65 to 74 years of age to have either cardiac catheterization (17% vs 43%) or any test for coronary artery disease severity (24% vs 53%). They were also less likely to have a test of left ventricular function (61% vs 76%). Even after adjustment for baseline characteristics, older patients remained less likely than younger patients to have an assessment of coronary artery disease severity (odds ratio, 0.44) or left ventricular function (odds ratio, 0.65). CONCLUSIONS Post-MI risk stratification declines with age and falls short of recommendations in our nation's elderly. This lack of testing may result in lost opportunities for therapeutic interventions in this high-risk group.

[1]  K. Anstrom,et al.  Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. , 2000, Journal of the American College of Cardiology.

[2]  K. Anstrom,et al.  Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. , 2000, Journal of the American College of Cardiology.

[3]  J S Alpert,et al.  1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) , 1999, Circulation.

[4]  A. Timmis,et al.  How should age affect management of acute myocardial infarction? A prospective cohort study , 1999, The Lancet.

[5]  J. Gurwitz,et al.  Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). , 1998, The American journal of cardiology.

[6]  R. Califf,et al.  Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial. , 1998, Journal of the American College of Cardiology.

[7]  H. Krumholz,et al.  Trends in the quality of care for Medicare beneficiaries admitted to the hospital with unstable angina. , 1998, Journal of the American College of Cardiology.

[8]  R. Califf,et al.  Clinical Guideline: Part II: Risk Stratification after Myocardial Infarction , 1997, Annals of Internal Medicine.

[9]  Richard P. Lewis,et al.  ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardio , 1997, Circulation.

[10]  R. Keller,et al.  The association between local diagnostic testing intensity and invasive cardiac procedures. , 1996, JAMA.

[11]  S. Paul,et al.  Geriatric patients with acute myocardial infarction: Cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. , 1996, American Heart Journal.

[12]  W. O’Neill,et al.  Regional variation across the United States in the management of acute myocardial infarction. , 1995, The New England journal of medicine.

[13]  E. Sowton,et al.  Percutaneous transluminal coronary angioplasty in patients 70 years of age or older: 12 years' experience. , 1995, British heart journal.

[14]  L Pilote,et al.  Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, The New England journal of medicine.

[15]  Erry,et al.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. , 1995, The New England journal of medicine.

[16]  D. Pryor,et al.  Changes in Mortality after Myocardial Revascularization in the Elderly: The National Medicare Experience , 1994, Annals of Internal Medicine.

[17]  G. Beller Are you ever too old to be risk stratified? , 1992, Journal of the American College of Cardiology.

[18]  P. Kudenchuk,et al.  Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. , 1991, Journal of the American College of Cardiology.

[19]  Richard P. Lewis,et al.  ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Clinical Application of Echocard , 1990, Circulation.

[20]  F. Klocke,et al.  Guidelines for the early management of patients with acute myocardial infarction , 1990 .

[21]  F. Klocke,et al.  ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early manag , 1990, Circulation.

[22]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[23]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[24]  R. Kronmal,et al.  Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry. , 1985, The New England journal of medicine.